These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38692064)

  • 21. [Non-occupational pleural mesothelioma].
    Petersen R; Petersen JA; Mikkelsen S
    Ugeskr Laeger; 2015 Jan; 177(3):V09140480. PubMed ID: 25613098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma.
    Yasumitsu A; Tabata C; Tabata R; Hirayama N; Murakami A; Yamada S; Terada T; Iida S; Tamura K; Fukuoka K; Kuribayashi K; Nakano T
    J Thorac Oncol; 2010 Apr; 5(4):479-83. PubMed ID: 20357617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The usefulness of biomarkers in diagnosis of asbestos-induced malignant pleural mesothelioma.
    Tanrıverdi Z; Meteroglu F; Yüce H; Şenyiğit A; Işcan M; Unüvar S
    Hum Exp Toxicol; 2021 Nov; 40(11):1817-1824. PubMed ID: 33998299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers.
    Johnen G; Burek K; Raiko I; Wichert K; Pesch B; Weber DG; Lehnert M; Casjens S; Hagemeyer O; Taeger D; Brüning T;
    Sci Rep; 2018 Sep; 8(1):14321. PubMed ID: 30254313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure.
    Rodríguez Portal JA; Rodríguez Becerra E; Rodríguez Rodríguez D; Alfageme Michavila I; Quero Martínez A; Diego Roza C; León Jiménez A; Isidro Montes I; Cebollero Rivas P
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):646-50. PubMed ID: 19190155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individual predictors of increased serum mesothelin in asbestos-exposed workers.
    Filiberti R; Marroni P; Mencoboni M; Mortara V; Caruso P; Cioè A; Michelazzi L; Merlo DF; Bruzzone A; Bobbio B; Del Corso L; Galli R; Taveggia P; Dini G; Spigno F
    Med Oncol; 2013 Mar; 30(1):422. PubMed ID: 23277285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pleural mesothelioma and occupational coexposure to asbestos, mineral wool, and silica.
    Lacourt A; Gramond C; Audignon S; Ducamp S; Févotte J; Soit Ilg AG; Goldberg M; Imbernon E; Brochard P
    Am J Respir Crit Care Med; 2013 May; 187(9):977-82. PubMed ID: 23471464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokines involved in the early inflammatory response and in pro-tumoral activity in asbestos-exposed workers from an Italian coastal area with territorial clusters of pleural malignant mesothelioma.
    Comar M; Zanotta N; Zanconati F; Cortale M; Bonotti A; Cristaudo A; Bovenzi M
    Lung Cancer; 2016 Apr; 94():61-7. PubMed ID: 26973208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.
    Watzka SB; Posch F; Pass HI; Flores RM; Hannigan GE; Bernhard D; Weber M; Mueller MR
    Eur J Cardiothorac Surg; 2013 May; 43(5):940-5. PubMed ID: 23045294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
    Mezei G; Chang ET; Mowat FS; Moolgavkar SH
    Scand J Work Environ Health; 2021 Jan; 47(1):85-86. PubMed ID: 32626907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calretinin as a blood-based biomarker for mesothelioma.
    Johnen G; Gawrych K; Raiko I; Casjens S; Pesch B; Weber DG; Taeger D; Lehnert M; Kollmeier J; Bauer T; Musk AW; Robinson BWS; Brüning T; Creaney J
    BMC Cancer; 2017 May; 17(1):386. PubMed ID: 28558669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study.
    Cvitanović S; Znaor L; Konsa T; Ivancević Z; Perić I; Erceg M; Vujović M; Vuković J; Beg-Zec Z
    Croat Med J; 2003 Oct; 44(5):618-25. PubMed ID: 14515425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of screening for malignant pleural mesothelioma.
    Pass HI; Carbone M
    Semin Thorac Cardiovasc Surg; 2009; 21(2):97-104. PubMed ID: 19822280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In commemoration of the 2018 Mataro Nagayo Prize: A road to early diagnosis and monitoring of asbestos-related mesothelioma.
    Hino O; Abe M; Han B; Yan Y
    Cancer Sci; 2019 May; 110(5):1518-1524. PubMed ID: 30888083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of biomarkers in asbestos-exposed workers as indicators of cancer risk.
    Amati M; Tomasetti M; Mariotti L; Tarquini LM; Valentino M; Santarelli L
    Mutat Res; 2008; 655(1-2):52-8. PubMed ID: 18638565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FBLN-3 as a biomarker of pleural plaques in workers occupationally exposed to carcinogenic fibers: a pilot study.
    Rapisarda V; Ledda C; Migliore M; Salemi R; Musumeci A; Bracci M; Marconi A; Loreto C; Libra M
    Future Oncol; 2015; 11(24 Suppl):35-7. PubMed ID: 26638921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATG5 as biomarker for early detection of malignant mesothelioma.
    Tomasetti M; Monaco F; Strogovets O; Volpini L; Valentino M; Amati M; Neuzil J; Santarelli L
    BMC Res Notes; 2023 Apr; 16(1):61. PubMed ID: 37095543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool.
    Ostroff RM; Mehan MR; Stewart A; Ayers D; Brody EN; Williams SA; Levin S; Black B; Harbut M; Carbone M; Goparaju C; Pass HI
    PLoS One; 2012; 7(10):e46091. PubMed ID: 23056237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative status and acute phase reactants in patients with environmental asbestos exposure and mesothelioma.
    Sezgi C; Taylan M; Sen HS; Evliyaoğlu O; Kaya H; Abakay O; Abakay A; Tanrıkulu AC; Senyiğit A
    ScientificWorldJournal; 2014; 2014():902748. PubMed ID: 24592197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune response profiling of malignant pleural mesothelioma for diagnostic and prognostic biomarkers.
    Creaney J; Dick IM; Musk AW; Olsen NJ; Robinson BW
    Biomarkers; 2016 Sep; 21(6):551-61. PubMed ID: 27009350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.